Artur Świerczek

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Topics

Rheumatoid Arthritis

Anti Inflammatory

Capillary Electrophoresis

Top Venues

Clinical and translational science

Pharmacological reports : PR

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Szczepan Mogilski, Monika Kubacka, Artur Świerczek, Elżbieta Wyska, Katarzyna Szczepańska, Jacek Sapa, Katarzyna Kieć-Kononowicz, Dorota Łażewska
Efficacy of the Multi-Target Compound E153 in Relieving Pain and Pruritus of Different Origins. Pharmaceuticals (Basel, Switzerland) 16 (10) (2023)
Monika Kubacka, Szczepan Mogilski, Marek Bednarski, Krzysztof Pociecha, Artur Świerczek, Noemi Nicosia, Jakub Schabikowski, Michał Załuski, Grażyna Chłoń-Rzepa, Jörg Hockemeyer, Christa Elisabeth Müller, Katarzyna Kieć-Kononowicz, Magdalena Kotańska
Antiplatelet Effects of Selected Xanthine-Based Adenosine A 2A and A 2B Receptor Antagonists Determined in Rat Blood. International journal of molecular sciences 24 (17) (2023)
Artur Świerczek, William J Jusko
Anti-Inflammatory Effects of Dexamethasone in COVID-19 Patients: Translational Population PK/PD Modeling and Simulation. Clinical and translational science (2023)
Artur Świerczek, Krzysztof Pociecha, Hanna Plutecka, Marietta Ślusarczyk, Grażyna Chłoń-Rzepa, Elżbieta Wyska
Pharmacokinetic/Pharmacodynamic Evaluation of a New Purine-2,6-Dione Derivative in Rodents with Experimental Autoimmune Diseases. Pharmaceutics 14 (5) (2022)
Małgorzata Zygmunt, Marietta Ślusarczyk, Agnieszka Jankowska, Artur Świerczek, Adrian Bryła, Szczepan Mogilski, Grzegorz Kazek, Jacek Sapa, Elżbieta Wyska, Grażyna Chłoń-Rzepa
Evaluation of analgesic and anti-inflammatory activity of purine-2,6-dione-based TRPA1 antagonists with PDE4/7 inhibitory activity. Pharmacological reports : PR 74 (5) (2022)
Artur Świerczek, Hanna Plutecka, Marietta Ślusarczyk, Grażyna Chłoń-Rzepa, Elżbieta Wyska
PK/PD Modeling of the PDE7 Inhibitor-GRMS-55 in a Mouse Model of Autoimmune Hepatitis. Pharmaceutics 13 (5) (2021)
Agnieszka Jankowska, Grzegorz Satała, Artur Świerczek, Krzysztof Pociecha, Anna Partyka, Magdalena Jastrzębska-Więsek, Monika Głuch-Lutwin, Andrzej J Bojarski, Elżbieta Wyska, Grażyna Chłoń-Rzepa
A new class of 5-HT1A receptor antagonists with procognitive and antidepressant properties. Future medicinal chemistry 13 (18) (2021)
Artur Świerczek, Elżbieta Wyska, Krzysztof Pociecha, Sebastian Baś, Jacek Mlynarski
Influence of inflammatory disorders on pharmacokinetics of lisofylline in rats: implications for studies in humans. Xenobiotica; the fate of foreign compounds in biological systems 49 (10) (2018)
Artur Świerczek, Elżbieta Wyska, Sebastian Baś, Marta Woyciechowska, Jacek Mlynarski
PK/PD studies on non-selective PDE inhibitors in rats using cAMP as a marker of pharmacological response. Naunyn-Schmiedeberg's archives of pharmacology 390 (10) (2017)